Effect of cyclosporin on plasma lipoprotein lipase activity in rats.
The effects of cyclosporin on plasma lipoproteins and lipoprotein lipase (LPL) activity were studied in rats treated with different doses of the drug for periods ranging between 7 and 30 days. The treatment with cyclosporin resulted in an increase in plasma triglycerides and non-HDL-cholesterol, and a dose and time-dependent decrease of LPL activity and HDL-cholesterol, mainly because of a fall in the HDL2-cholesterol subfraction. The decrease of LPL activity was positively correlated (p < 0.01) with plasma HDL-cholesterol and HDL2-cholesterol and negatively with plasma triglycerides and non-HDL-cholesterol (p < 0.01). Our results indicate that the decrease in plasma LPL activity may be responsible for the increase in plasma triglycerides and the decrease in plasma HDL-cholesterol found in rats under cyclosporin treatment.
López-Miranda
J
J
Unidad de Lipidos y Arteriosclerosis, Hopital Universitario Reina Sofia, Cordoba, Spain.
Pérez-Jiménez
F
F
Gómez-Gerique
J A
JA
Espino-Montoro
A
A
Hidalgo-Rojas
L
L
Pedreño
J
J
Jiménez-Perepérez
J A
JA
D000818:Animals; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000494:pharmacology*; D008071:Lipoprotein Lipase / Q000097:blood*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014280:Triglycerides / Q000097:blood
D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D008071:Lipoprotein Lipase